Sugi Predict

Sugi Predict / Compounds / SCHEMBL6955027

SCHEMBL6955027

SCHEMBL6955027

CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N1CCCC(C(=O)N(CC)CC)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.44
▸ BCHE P06276 1/20 0.44
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KDM4E B2RXH2 4/20 0.39
▸ LMNA P02545 3/20 0.39
▸ MMP1 P03956 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ SAE1 Q9UBE0 1/20 0.39
▸ UBA2 Q9UBT2 1/20 0.39
▸ NAMPT P43490 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7065389 1.00 HPGD (0.44) HPGDBCHEALDH1A1MAPTMAPK1
SCHEMBL7069250 0.88 LMNA (0.50) BCHEALDH1A1MAPK1LMNAMMP1
SCHEMBL6956637 0.88 LMNA (0.50) BCHEALDH1A1MAPK1LMNAMMP1
SCHEMBL6956635 0.88 LMNA (0.50) BCHEALDH1A1MAPK1LMNAMMP1
SCHEMBL7068510 0.86 XPNPEP2 (0.43) ALDH1A1MAPK1LMNAMMP1MMP2
SCHEMBL6954392 0.86 XPNPEP2 (0.43) ALDH1A1MAPK1LMNAMMP1MMP2
SCHEMBL6954395 0.86 XPNPEP2 (0.43) ALDH1A1MAPK1LMNAMMP1MMP2
SCHEMBL7067800 0.83 ALDH1A1 (0.50) HPGDALDH1A1MAPTTSHRHTT
SCHEMBL6954284 0.83 ALDH1A1 (0.50) HPGDALDH1A1MAPTTSHRHTT
SCHEMBL6954285 0.83 ALDH1A1 (0.50) HPGDALDH1A1MAPTTSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232985-A1 Succinoylamino heterocycles as inhibitors of a beta protein production THOMPSON LORIN A (US) 2003-12-18 — — US disclosed
US-20030073701-A1 Succinoylamino heterocycles as inhibitors of a beta protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-04-17 — — US disclosed
EP-1268454-A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 — — EP disclosed
WO-2001074796-A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073701-A1 Succinoylamino heterocycles as inhibitors of a beta protein production APP, BACE1, APH1A HPGD 1106/4885BCHE 144/4885ALDH1A1 3091/4885
US-20030232985-A1 Succinoylamino heterocycles as inhibitors of a beta protein production APP, BACE1, APH1A HPGD 1106/4885BCHE 144/4885ALDH1A1 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.